David Vera

Title(s)Adjunct Professor, Radiology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, DavisPh.D. degree in Biophysics
    University of California, San FranciscoB.S. degree in BiologySchool of Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    Renal Molecular Imaging of Mesangial Cell Function with Tc-99m-Tilmanocept
    NIH R01DK127201Apr 1, 2021 - Feb 28, 2024
    Role: Co-Principal Investigator
    MR Solutions Benchtop Cryogen Free Superconducting 1.5T/3.0T Rodent MR Scanner
    NIH S10OD018225Apr 17, 2015 - Oct 16, 2016
    Role: Co-Principal Investigator
    In Vivo Cellular and Molecular Imaging Centers (ICMICs)
    NIH P50CA128346Sep 23, 2008 - Aug 31, 2014
    Role: Principal Investigator
    In Vivo Cellular and Molecular Imaging Centers (ICMICs)
    NIH P20CA134224Sep 28, 2007 - Aug 31, 2009
    Role: Principal Investigator
    Workshop on Molecular Imaging Agents
    NIH R13CA126365Apr 1, 2007 - Mar 31, 2008
    Role: Principal Investigator
    Size-Dependent Uptake of Tc(I)-Labeled RGD Analogs
    NIH R41CA112797Jan 12, 2005 - Dec 31, 2006
    Role: Principal Investigator
    Workshop on Receptor-Binding Radiotracers 2003
    NIH R13CA101304Feb 10, 2003 - Jan 31, 2004
    Role: Principal Investigator
    BLOOD POOL CONTRAST AGENTS FOR CT AND MRI
    NIH R01EB002111Apr 1, 2000 - Mar 31, 2005
    Role: Principal Investigator
    BLOOD POOL CONTRAST AGENTS FOR CT AND MRI
    NIH R01CA082335Apr 1, 2000 - Mar 31, 2004
    Role: Principal Investigator
    RECEPTOR BINDING RADIOTRACER FOR SENTINEL NODE IMAGING
    NIH R01CA072751Feb 1, 1997 - Jan 31, 2002
    Role: Principal Investigator
    RECEPTOR-BASED RADIOTRACERS FOR CARDIOVASCULAR IMAGING
    NIH R01HL035346Dec 1, 1985 - Nov 30, 1986
    Role: Principal Investigator
    VALIDATION OF A KINETIC MODEL FOR RECEPTOR IMAGING
    NIH R01DK034768Dec 1, 1984 - Mar 31, 1996
    Role: Principal Investigator
    VALIDATION OF A KINETIC MODEL FOR RECEPTOR IMAGING
    NIH R23AM034768Dec 1, 1984 - Nov 30, 1985
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. Sci Adv. 2020 Jun; 6(26):eaba4353. Svensson MND, Zoccheddu M, Yang S, Nygaard G, Secchi C, Doody KM, Slowikowski K, Mizoguchi F, Humby F, Hands R, Santelli E, Sacchetti C, Wakabayashi K, Wu DJ, Barback C, Ai R, Wang W, Sims GP, Mydel P, Kasama T, Boyle DL, Galimi F, Vera D, Tremblay ML, Raychaudhuri S, Brenner MB, Firestein GS, Pitzalis C, Ekwall AH, Stanford SM, Bottini N. PMID: 32637608.
      View in: PubMed   Mentions: 3     Fields:    
    2. Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation. Nucl Med Biol. 2021 01; 92:5-23. Krohn KA, Vera DR. PMID: 32331709.
      View in: PubMed   Mentions: 1     Fields:    
    3. A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [99mTc]Tc-tilmanocept. Nucl Med Biol. 2021 01; 92:107-114. Chen W, Barback CV, Wang S, Hoh CK, Chang EY, Hall DJ, Head BP, Vera DR. PMID: 32169304.
      View in: PubMed   Mentions:    Fields:    
    4. Molecular Imaging of the Glomerulus via Mesangial Cell Uptake of Radiolabeled Tilmanocept. J Nucl Med. 2019 09; 60(9):1325-1332. Qin Z, Hoh CK, Olson ES, Jahromi AH, Hall DJ, Barback CV, You YH, Yanagita M, Sharma K, Vera DR. PMID: 30796169.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    5. Effect of overnight smoking abstinence on a marker for microglial activation: a [11C]DAA1106 positron emission tomography study. Psychopharmacology (Berl). 2018 Dec; 235(12):3525-3534. Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, Kotta KK, London ED, Okita K, Nurmi EL, Seaman LC, Mandelkern MA. PMID: 30343364.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    6. Molecular Imaging of endometrial sentinel lymph nodes utilizing fluorescent-labeled Tilmanocept during robotic-assisted surgery in a porcine model. PLoS One. 2018; 13(7):e0197842. Anderson KM, Barback CV, Qin Z, Hall DJ, Hoh CK, Vera DR, McHale MT. PMID: 29965996.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    7. Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept. EJNMMI Res. 2017 Dec; 7(1):40. Varasteh Z, Hyafil F, Anizan N, Diallo D, Aid-Launais R, Mohanta S, Li Y, Braeuer M, Steiger K, Vigne J, Qin Z, Nekolla SG, Fabre JE, Döring Y, Le Guludec D, Habenicht A, Vera DR, Schwaiger M. PMID: 28470406.
      View in: PubMed   Mentions:
    8. Fluorescence-Based Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes. J Nucl Med. 2017 04; 58(4):547-553. Lee HJ, Barback CV, Hoh CK, Qin Z, Kader K, Hall DJ, Vera DR, Kane CJ. PMID: 28153955.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    9. Assessment of in vivo systemic toxicity and biodistribution of iron-doped silica nanoshells. Nanomedicine. 2017 04; 13(3):933-942. Mendez N, Liberman A, Corbeil J, Barback C, Viveros R, Wang J, Wang-Rodriguez J, Blair SL, Mattrey R, Vera D, Trogler W, Kummel AC. PMID: 27840314.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    10. New Dioxaborolane Chemistry Enables [(18)F]-Positron-Emitting, Fluorescent [(18)F]-Multimodality Biomolecule Generation from the Solid Phase. Bioconjug Chem. 2016 05 18; 27(5):1390-1399. Rodriguez EA, Wang Y, Crisp JL, Vera DR, Tsien RY, Ting R. PMID: 27064381.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    11. Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models. Nucl Med Biol. 2016 Feb; 43(2):179-87. Schnabl B, Farshchi-Heydari S, Loomba R, Mattrey RF, Hoh CK, Sirlin CB, Brenner DA, Behling CA, Vera DR. PMID: 26872443.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    12. Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S559-65. Unkart JT, Baker JL, Hosseini A, Hoh CK, Wallace MS, Vera DR, Wallace AM. PMID: 26275779.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    13. A tri-modal molecular imaging agent for sentinel lymph node mapping. Nucl Med Biol. 2015 Dec; 42(12):917-22. Qin Z, Hoh CK, Hall DJ, Vera DR. PMID: 26320812.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    14. ?-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206). J Immunol. 2015 Sep 01; 195(5):2019-29. Azad AK, Rajaram MV, Metz WL, Cope FO, Blue MS, Vera DR, Schlesinger LS. PMID: 26202986.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    15. Sentinel lymph node biopsy in bladder cancer: Systematic review and technology update. Indian J Urol. 2015 Jul-Sep; 31(3):170-5. Liss MA, Noguchi J, Lee HJ, Vera DR, Kader AK. PMID: 26166959.
      View in: PubMed   Mentions:
    16. Robotic-assisted fluorescence sentinel lymph node mapping using multimodal image guidance in an animal model. Urology. 2014 Oct; 84(4):982.e9-14. Liss MA, Stroup SP, Qin Z, Hoh CK, Hall DJ, Vera DR, Kane CJ. PMID: 25139676.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    17. Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients. Ann Surg Oncol. 2015 Jan; 22(1):40-5. Baker JL, Pu M, Tokin CA, Hoh CK, Vera DR, Messer K, Wallace AM. PMID: 25069859.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    18. Preclinical evaluation of robotic-assisted sentinel lymph node fluorescence imaging. J Nucl Med. 2014 Sep; 55(9):1552-6. Liss MA, Farshchi-Heydari S, Qin Z, Hickey SA, Hall DJ, Kane CJ, Vera DR. PMID: 25024425.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    19. Fluorescent-tilmanocept for tumor margin analysis in the mouse model. J Surg Res. 2014 Aug; 190(2):528-34. Hosseini A, Baker JL, Tokin CA, Qin Z, Hall DJ, Stupak DG, Hayashi T, Wallace AM, Vera DR. PMID: 24923630.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    20. Cold wall effect eliminating method to determine the contrast recovery coefficient for small animal PET scanners using the NEMA NU-4 image quality phantom. Phys Med Biol. 2014 Jun 07; 59(11):2727-46. Lajtos I, Czernin J, Dahlbom M, Daver F, Emri M, Farshchi-Heydari S, Forgacs A, Hoh CK, Joszai I, Krizsan AK, Lantos J, Major P, Molnar J, Opposits G, Tron L, Vera DR, Balkay L. PMID: 24800813.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    21. 68Ga chelating bioorthogonal tetrazine polymers for the multistep labeling of cancer biomarkers. Chem Commun (Camb). 2014 May 25; 50(40):5215-5217. Nichols B, Qin Z, Yang J, Vera DR, Devaraj NK. PMID: 24589653.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    22. Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes. J Biomed Opt. 2013 Oct; 18(10):101315. Qin Z, Hall DJ, Liss MA, Hoh CK, Kane CJ, Wallace AM, Vera DR. PMID: 23958947.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    23. Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells. ACS Nano. 2013 Jul 23; 7(7):6367-77. Liberman A, Wu Z, Barback CV, Viveros R, Blair SL, Ellies LG, Vera DR, Mattrey RF, Kummel AC, Trogler WC. PMID: 23802554.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    24. Development of 68Ga-labelled DTPA galactosyl human serum albumin for liver function imaging. Eur J Nucl Med Mol Imaging. 2013 Aug; 40(8):1245-55. Haubner R, Vera DR, Farshchi-Heydari S, Helbok A, Rangger C, Putzer D, Virgolini IJ. PMID: 23579865.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    25. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials. Ann Surg Oncol. 2013 Aug; 20(8):2590-9. Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera DR. PMID: 23504141.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    26. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology. 2012 Oct; 265(1):186-93. Emerson DK, Limmer KK, Hall DJ, Han SH, Eckelman WC, Kane CJ, Wallace AM, Vera DR. PMID: 22753678.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    27. The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ??mTc-labeled nanocolloid human serum albumin standard of care. Clin Exp Metastasis. 2012 Oct; 29(7):681-6. Tokin CA, Cope FO, Metz WL, Blue MS, Potter BM, Abbruzzese BC, Hartman RD, Joy MT, King DW, Christman LA, Vera DR, Wallace AM. PMID: 22729510.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model. Clin Exp Metastasis. 2012 Oct; 29(7):673-80. Stroup SP, Kane CJ, Farchshchi-Heydari S, James CM, Davis CH, Wallace AM, Hoh CK, Vera DR. PMID: 22714690.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    29. Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes. Bioconjug Chem. 2010 Oct 20; 21(10):1811-9. Ting R, Aguilera TA, Crisp JL, Hall DJ, Eckelman WC, Vera DR, Tsien RY. PMID: 20873712.
      View in: PubMed   Mentions: 32     Fields:    Translation:Animals
    30. Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol. Nucl Med Biol. 2009 Aug; 36(6):687-92. Wallace AM, Hoh CK, Limmer KK, Darrah DD, Schulteis G, Vera DR. PMID: 19647175.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    31. Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts. Cancer Chemother Pharmacol. 2010 Feb; 65(3):515-26. Wang X, Zhao G, Van S, Jiang N, Yu L, Vera D, Howell SB. PMID: 19593566.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    32. mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc Natl Acad Sci U S A. 2009 Jul 07; 106(27):11137-42. Shackelford DB, Vasquez DS, Corbeil J, Wu S, Leblanc M, Wu CL, Vera DR, Shaw RJ. PMID: 19541609.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansAnimalsCells
    33. Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function. Am J Physiol Renal Physiol. 2009 Jul; 297(1):F210-7. Wu W, Kitamura S, Truong DM, Rieg T, Vallon V, Sakurai H, Bush KT, Vera DR, Ross RS, Nigam SK. PMID: 19439520.
      View in: PubMed   Mentions: 32     Fields:    Translation:Animals
    34. After bench to bedside: the impact of disease progression, commercial opportunities and available instrumentation on clinical outcome. Nucl Med Biol. 2007 Oct; 34(7):727-8. Eckelman WC, Vera DR. PMID: 17921023.
      View in: PubMed   Mentions: 1     Fields:    
    35. Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek. Nucl Med Biol. 2007 Oct; 34(7):849-53. Wallace AM, Hoh CK, Darrah DD, Schulteis G, Vera DR. PMID: 17921035.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    36. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET. Nucl Med Commun. 2007 Jan; 28(1):7-13. Obrzut S, Pham RH, Vera DR, Badran K, Hoha CK. PMID: 17159543.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    37. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol. 2007 Feb; 14(2):913-21. Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera DR. PMID: 17146742.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    38. Molecular targeting of the lymphovascular system for imaging and therapy. Cancer Metastasis Rev. 2006 Jun; 25(2):185-201. Schöder H, Glass EC, Pecking AP, Harness JK, Wallace AM, Hirnle P, Alberini JL, Vilain D, Larson SM, Hoh CK, Vera DR. PMID: 16770532.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCTClinical Trials
    39. A preclinical study of prostate sentinel lymph node mapping with [99mTC]diethylenetetramine pentaacetic acid-mannosyl-dextran. J Urol. 2006 Feb; 175(2):744-8. Salem CE, Hoh CK, Wallace AM, Vera DR. PMID: 16407043.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    40. Minimally invasive sentinel lymph node mapping of the pig colon with Lymphoseek. Surgery. 2006 Feb; 139(2):217-23. Wallace AM, Ellner SJ, Méndez J, Hoh CK, Salem CE, Bosch CM, Orahood RC, Vera DR. PMID: 16455331.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    41. What is to be gained by imaging the same animal before and after treatment? Nucl Med Biol. 2005 Oct; 32(7):727-32. Scheibe PO, Vera DR, Eckelman WC. PMID: 16243648.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    42. Breast imaging: a surgeon's prospective. Nucl Med Biol. 2005 Oct; 32(7):781-92. Wallace AM, Comstock C, Hoh CK, Vera DR. PMID: 16243654.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry. Nucl Med Biol. 2005 Oct; 32(7):687-93. Vera DR, Hall DJ, Hoh CK, Gallant P, McIntosh LM, Mattrey RF. PMID: 16243643.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    44. Are there lessons to be learned from drug development that will accelerate the use of molecular imaging probes in the clinic? Nucl Med Biol. 2005 Oct; 32(7):657-62. Eckelman WC, Rohatagi S, Krohn KA, Vera DR. PMID: 16243639.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    45. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad Radiol. 2004 Dec; 11(12):1361-9. Sirlin CB, Vera DR, Corbeil JA, Caballero MB, Buxton RB, Mattrey RF. PMID: 15596374.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    46. Sentinel lymph node mapping of the colon and stomach using lymphoseek in a pig model. Ann Surg Oncol. 2004 Jul; 11(7):674-81. Ellner SJ, Méndez J, Vera DR, Hoh CK, Ashburn WL, Wallace AM. PMID: 15231522.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    47. Clinical application of TcGSA. Nucl Med Biol. 2003 Nov; 30(8):845-9. Kokudo N, Vera DR, Makuuchi M. PMID: 14698788.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    48. From bench to bedside. Nucl Med Biol. 2003 Nov; 30(8):793-4. Eckelman WC, Vera DR. PMID: 14698781.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    49. Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping. Nucl Med Biol. 2003 Nov; 30(8):805-10. Ellner SJ, Hoh CK, Vera DR, Darrah DD, Schulteis G, Wallace AM. PMID: 14698783.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    50. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs. J Nucl Med. 2003 Oct; 44(10):1677-81. Méndez J, Wallace AM, Hoh CK, Vera DR. PMID: 14530486.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    51. Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran . Nucl Med Biol. 2003 Jul; 30(5):457-64. Hoh CK, Wallace AM, Vera DR. PMID: 12831982.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsPHPublic Health
    52. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol. 2003 Jun; 10(5):531-8. Wallace AM, Hoh CK, Vera DR, Darrah DD, Schulteis G. PMID: 12794019.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCellsCTClinical Trials
    53. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg. 2002 Nov; 26(11):1342-7. Kokudo N, Vera DR, Tada K, Koizumi M, Seki M, Matsubara T, Ohta H, Yamaguchi T, Takahashi T, Nakajima T, Muto T. PMID: 12297928.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    54. A molecular CT blood pool contrast agent. Acad Radiol. 2002 Jul; 9(7):784-92. Vera DR, Mattrey RF. PMID: 12139092.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    55. [(99m)Tc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection. Nucl Med Biol. 2001 Jul; 28(5):493-8. Vera DR, Wallace AM, Hoh CK. PMID: 11516693.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    David's Networks
    Concepts (262)
    Derived automatically from this person's publications.
    _
    Co-Authors (40)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _